Internal Medicine News - Orally disintegrating alprazolam
May 1, 2005 -- Niravam (alprazolam) orally disintegrating tablets are approved for the treatment of generalized anxiety disorder and panic disorder. For more...
Clinical Psychiatry News - Orally disintegrating alprazolam
April 1, 2005 -- Niravam (alprazolam) orally disintegrating tablets are approved for the treatment of generalized anxiety disorder and panic disorder. For more...
Business Wire - Teva Announces Approval of Alprazolam ER Tablets
March 1, 2007 -- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. Food and Drug Administration has granted approval for...
Biotech Business - NOVADEL INITIATES HUMAN STUDY OF ALPRAZOLAM LINGUAL SPRAY.
November 1, 2004 -- NovaDel Pharma Inc. (AMEX:NVD), Flemmington, N.J., has commenced a pilot pharmacokinetic feasibility study in humans of a lingual spray version of...
Business Wire - NovaDel Pharma Announces Positive Pharmacokinetic Study Results for Alprazolam Lingual Spray
April 27, 2005 -- FLEMINGTON, N.J. -- Preliminary Results Show Rapid Rate of Absorption and Onset of Pharmacodynamic Effects for NovaDel's Lingual Spray Compared to...
Deseret News (Salt Lake City) - Mom who didn't call 911 is fit for trial
July 5, 2008 -- PROVO -- A mother who failed to call 911 when her daughter overdosed has been declared mentally fit to stand trial. Traci Sorenson, 45, was...
Jet - Sean Levert's widow files wrongful death lawsuit; coroner rules singer died of natural causes
June 23, 2008 -- The widow of R&B singer Sean Levert has filed a wrongful death lawsuit against the county officials who were holding him in Cleveland's Cuyahoga...
Healthfacts - Is your drug an anticholinergic?
June 1, 2008 -- Ask your pharmacist or doctor whether a drug you are taking is an anticholinergic. The usual advice--read the written material that comes with the...
Business Wire - McKesson Announces Settlement with DEA
May 2, 2008 -- Company Signed Settlement to Minimize Impact to Customers, Suppliers and Investors SAN FRANCISCO -- McKesson Corporation (NYSE:MCK) today announced...
